Daniela Bruni
Immunology · 2018–2020
A researcher in the Science corpus: 3 papers; trusts 4 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Immunology — 140 citations into it
- Oncology — 137 citations into it
Whom Daniela Bruni trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Daniela Bruni's perspective
Ordered by how strongly the researchers Daniela Bruni trusts endorse each paper. Same corpus, a different order for every researcher.
- Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome (Science)
- Hallmarks of cancer: the next generation. (Cell)
- Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival (Nature Medicine)
- In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer. (Journal of Clinical Oncology)
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma (New England Journal of Medicine)
- Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. (New England Journal of Medicine)
- Cancer-related inflammation (Nature)
- The blockade of immune checkpoints in cancer immunotherapy (Nature Reviews. Cancer)
- Molecular and genetic properties of tumors associated with local immune cytolytic activity (Cell)
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer (New England Journal of Medicine)
Their papers
- The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy (2020) — 1,336 citations
- Approaches to treat immune hot, altered and cold tumours with combination immunotherapies (2019) — 2,840 citations
- International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study. (2018) — 1,778 citations